Torax Medical

Name

Torax Medical

Legal name

Torax Medical, Inc.

Website

https://toraxmedical.com

Company type

Private

Founded year

2002

Operating status

Acquired

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Anti-Reflux Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

akta.pro secondary industry

General Gastroenterology (HLAKAEAA)

Keywords

• Magnetic sphincter augmentation
• Anti-reflux medical devices
• Laparoscopic surgical implants
• GERD treatment devices
• Esophageal sphincter devices

Headquarters

HQ city

Saint Paul

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales (LINX Implant): The LINX Reflux Management System generates revenue through the sale of the implantable medical device to hospitals and surgical centers. The device is a one-time implantable product used in laparoscopic anti-reflux procedures.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Torax Medical develops and manufactures the LINX Reflux Management System, a laparoscopic, fundic-sparing implantable medical device for the treatment of gastroesophageal reflux disease (GERD). The device consists of a flexible ring of small magnetic beads placed around the lower esophageal sphincter (LES) to augment its function, preventing reflux while allowing normal swallowing. It is sold to hospitals and surgical centers and is now marketed through Johnson & Johnson MedTech following Torax Medical's acquisition by Ethicon.

Product overview

Torax Medical specializes in the LINX™ Reflux Management System, a single core product comprising a flexible ring of magnetic beads for laparoscopic placement around the lower esophageal sphincter. The device is available in multiple product codes (LST, LXMC13-LXMC17) and is indicated for GERD patients seeking an alternative to continuous acid suppression therapy. The system is designed to augment the weak sphincter without compressing the esophagus, preserving physiologic function including the ability to belch and vomit.

Differentiator

Problem solved

Functional benefit

Products and services

• LINX Reflux Management System Laparoscopic, fundic-sparing anti-reflux implantable medical device indicated for adult patients diagnosed with gastroesophageal reflux disease (GERD). The system consists of a flexible ring of small titanium magnetic beads placed around the lower esophageal sphincter (LES); the magnet strength is precisely calibrated to keep the weak LES closed to prevent reflux while allowing it to open temporarily during swallowing to permit food and liquid to pass. Available in multiple product codes (LST, LXMC13, LXMC14, LXMC15, LXMC16, LXMC17) and sold to hospitals and ambulatory surgical centers.

Quantifiable outcome

• 99% of patients reported no regurgitation 5 years after LINX treatment (baseline 57% decreased to 1.2%)
• +4 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• American College of Gastroenterology (ACG)coreStrategic or Co-development PartnerACG 2022 guidelines include LINX as an effective surgical option for patients with evidence of GERD, providing clinical guidance support for the device.
• American Gastroenterological Association (AGA)coreStrategic or Co-development PartnerAGA 2022 practice updates include LINX as an effective surgical option for patients with evidence of GERD, providing clinical guidance support for the device.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• EndoGastric Solutions: Developer of the EsophyX device for transoral incisionless fundoplication (TIF), a direct competing procedural alternative to LINX for the surgical treatment of GERD. Targets the same PPI-refractory patient population and competes head-to-head for surgeon adoption and payer coverage.
• Medigus: Markets the Medigus Ultrasonic Surgical Endostapler (MUSE), an endoscopic stapling system for performing anterior fundoplication in GERD patients. Competes with LINX in the minimally invasive anti-reflux surgery category.

Broad incumbents

• Ethicon (Johnson & Johnson MedTech): Torax's parent company and a broad incumbent in surgical devices, with overlapping energy/harmonic surgical platforms and the wider J&J MedTech portfolio that distributes LINX. Comparable as the integrated commercial and clinical environment in which LINX operates.
• Medtronic: Global medical device incumbent with a significant surgical and GI presence, including energy devices and stapling platforms used in laparoscopic anti-reflux procedures. Comparable as a broad incumbent competing for hospital surgical budgets and surgeon mindshare.
• Boston Scientific: Diversified medical device company with GI/surgical franchises and endoscopy adjacencies. Comparable as a broad incumbent in the procedural GI space where LINX competes for procedural slots and payer coverage.
• Stryker: Large surgical and endoscopy device manufacturer with laparoscopic instrument and surgical equipment lines sold to the same hospital and ASC customers that purchase LINX. Comparable as an incumbent competing for surgical-suite share.
• Olympus: Leading endoscopy and GI procedural device company whose therapeutic endoscopy platforms are used by the same gastroenterologists who manage GERD. Comparable as an incumbent in the GI procedural ecosystem adjacent to LINX.
• Pentax Medical (HOYA): Endoscopy-focused business unit of HOYA, supplying diagnostic and therapeutic endoscopy equipment to the gastroenterology community. Comparable as an incumbent providing tools used by the same specialists who evaluate LINX candidates.

Emerging players

• Apollo Endosurgery: Focused on minimally invasive endoscopic devices for GI disorders, including endoluminal suturing systems that intersect with the GERD procedural space. Comparable as a peer in endoscopic/surgical GI device development.
• ReShape Lifesciences: Medical device company with GI and bariatric surgery adjacencies, including minimally invasive tools targeting the obesity/reflux patient population that overlaps with LINX post-bariatric and primary GERD indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/torax-medical-inc-

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds8 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Torax Medical